PMV Pharmaceuticals, Inc. (PMVP) Misses Q2 EPS by 2c

PMV Pharmaceuticals, Inc. (NASDAQ: PMVP) reported Q2 EPS of ($0.41), $0.02 worse than the analyst estimate of ($0.39).

For earnings history and earnings-related data on PMV Pharmaceuticals, Inc. (PMVP) click here.

You May Also Be Interested In

• loanDepot receives NYSE non-compliance notice over stock price
• OBOOK Holdings posts $18.8M net loss as OwlPay Harbor volume rises
• Nuvectis Pharma (NVCT) files $200M mixed shelf